The Journal of Immunology, Vol 155, Issue 3 1361-1369, Copyright © 1995 by American Association of Immunologists

ARTICLES

Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages

RW Stokes and DP Speert
Division of Infectious and Immunologic Diseases, British Columbia's Children's Hospital, Vancouver, Canada.

The initial phagocytic interaction between Mycobacterium tuberculosis and macrophages (M phi) in the lung is probably nonopsonic, which would mean that M phi receptors will bind directly to bacterial ligands without the involvement of serum opsonins. Lipoarabinomannan (LAM) is a major component of the cell wall of mycobacteria. The possibility that LAM is involved in the nonopsonic binding of M. tuberculosis to M phi was investigated by using competitive inhibition assays. LAM inhibited binding of M. tuberculosis to murine peritoneal M phi in a dose- dependent manner. LAM also inhibited the binding of Mycobacterium avium and Mycobacterium bovis BCG to M phi. Phosphatidylinositol mannoside and lipomannan have the same phosphatidylinositol (PI) moiety as LAM, but differ in their glycosylation patterns. Both molecules inhibited binding of M. tuberculosis to M phi. Deacylation of LAM abrogated its capacity to inhibit binding of M. tuberculosis to M phi. These observations indicated that it was the PI moiety of LAM that was important in mediating its inhibitory properties. In support of this hypothesis, commercial PI was shown to inhibit the binding of M. tuberculosis to M phi. Our results suggest that cellfree LAM is able to inhibit the binding of mycobacteria to M phi, but that it does not do so by competing with any interaction between M phi receptors and cell- associated LAM, because the PI end of the molecule is believed to be anchored in the bacterial plasma membrane, and therefore not available as a ligand on the cell surface. However, LAM that is released from M. tuberculosis in the course of its active replication during infection may be able to interfere with the phagocytic clearance of mycobacteria.

This article has been cited by other articles:

				R. Goude, A. G. Amin, D. Chatterjee, and T. Parish The Critical Role of embC in Mycobacterium tuberculosis J. Bacteriol., June 15, 2008; 190(12): 4335 - 4341. [Abstract] [Full Text] [PDF]

				J. Garcia, A. Puentes, L. Rodriguez, M. Ocampo, H. Curtidor, R. Vera, R. Lopez, J. Valbuena, J. Cortes, M. Vanegas, et al. Mycobacterium tuberculosis Rv2536 protein implicated in specific binding to human cell lines Protein Sci., September 1, 2005; 14(9): 2236 - 2245. [Abstract] [Full Text] [PDF]

				C. Villeneuve, M. Gilleron, I. Maridonneau-Parini, M. Daffe, C. Astarie-Dequeker, and G. Etienne Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process J. Lipid Res., March 1, 2005; 46(3): 475 - 483. [Abstract] [Full Text] [PDF]

				S. Berg, J. Starbuck, J. B. Torrelles, V. D. Vissa, D. C. Crick, D. Chatterjee, and P. J. Brennan Roles of Conserved Proline and Glycosyltransferase Motifs of EmbC in Biosynthesis of Lipoarabinomannan J. Biol. Chem., February 18, 2005; 280(7): 5651 - 5663. [Abstract] [Full Text] [PDF]

				L. M. Thorson, D. Doxsee, M. G. Scott, P. Wheeler, and R. W. Stokes Effect of Mycobacterial Phospholipids on Interaction of Mycobacterium tuberculosis with Macrophages Infect. Immun., April 1, 2001; 69(4): 2172 - 2179. [Abstract] [Full Text] [PDF]

				A. P. Koets, V. P. M. G. Rutten, M. de Boer, D. Bakker, P. Valentin-Weigand, and W. van Eden Differential Changes in Heat Shock Protein-, Lipoarabinomannan-, and Purified Protein Derivative-Specific Immunoglobulin G1 and G2 Isotype Responses during Bovine Mycobacterium avium subsp. paratuberculosis Infection Infect. Immun., March 1, 2001; 69(3): 1492 - 1498. [Abstract] [Full Text] [PDF]

				J. Zabaleta, M. Arias, J. R. Maya, and L. F. García Diminished Adherence and/or Ingestion of Virulent Mycobacterium tuberculosis by Monocyte-Derived Macrophages from Patients with Tuberculosis Clin. Vaccine Immunol., September 1, 1998; 5(5): 690 - 694. [Abstract] [Full Text]

				B. K. Kang and L. S. Schlesinger Characterization of Mannose Receptor-Dependent Phagocytosis Mediated by Mycobacterium tuberculosis Lipoarabinomannan Infect. Immun., June 1, 1998; 66(6): 2769 - 2777. [Abstract] [Full Text] [PDF]

				G. Hetland, H. G. Wiker, K. Høgåsen, B. Hamasur, S. B. Svenson, and M. Harboe Involvement of Antilipoarabinomannan Antibodies in Classical Complement Activation in Tuberculosis Clin. Vaccine Immunol., March 1, 1998; 5(2): 211 - 218. [Abstract] [Full Text]